|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.14 CNY | -2.40% |
|
+0.19% | -15.81% |
| Capitalization | 8.74B 1.22B 1.05B 989M 896M 1.65B 105B 1.87B 11.55B 4.5B 48B 4.57B 4.47B 175B | P/E ratio 2025 * |
14.5x | P/E ratio 2026 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise value | 8.74B 1.22B 1.05B 989M 896M 1.65B 105B 1.87B 11.55B 4.5B 48B 4.57B 4.47B 175B | EV / Sales 2025 * |
6.49x | EV / Sales 2026 * | 5.86x |
| Free-Float |
22.45% | Yield 2025 * |
0.9% | Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | -2.40% | ||
| 1 week | +0.19% | ||
| Current month | +0.19% | ||
| 1 month | +1.39% | ||
| 3 months | -9.97% | ||
| 6 months | -21.99% | ||
| Current year | -15.81% |
| 1 week | 21.11 |  | 21.89 |
| 1 month | 20.51 | | 21.89 |
| Current year | 20.19 | | 25.15 |
| 1 year | 20.19 | | 36.05 |
| 3 years | 20.19 | | 78.39 |
| 5 years | 20.19 | | 135.88 |
| 10 years | 20.19 | | 135.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Kong
CEO | Chief Executive Officer | 60 | 2003-12-31 |
Zhao Feng Meng
DFI | Director of Finance/CFO | 61 | 2019-01-31 |
Chang Lin Zhu
CTO | Chief Tech/Sci/R&D Officer | 57 | 2003-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Feng Li
BRD | Director/Board Member | 56 | 2004-02-29 |
Yun Tao Jiang
BRD | Director/Board Member | 51 | 2018-06-30 |
Wei Kong
BRD | Director/Board Member | 60 | 2003-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.40% | +0.19% | -32.70% | -55.19% | 1.22B | ||
| -0.09% | -1.12% | -33.08% | -29.80% | 57.7B | ||
| +0.26% | +1.50% | -8.15% | -11.11% | 9.05B | ||
| -1.03% | -0.50% | +9.05% | +20.95% | 6.65B | ||
| -1.75% | +2.60% | +42.95% | +116.64% | 5.8B | ||
| -3.42% | -0.11% | +15.33% | +27.00% | 5.18B | ||
| -1.97% | +1.33% | +67.41% | +16.93% | 3.71B | ||
| -1.55% | +0.74% | -0.91% | +20.47% | 2.02B | ||
| -2.26% | -3.38% | +23.24% | +16.77% | 1.79B | ||
| -3.26% | -5.29% | -61.13% | -6.05% | 1.75B | ||
| Average | -1.64% | -1.63% | +2.20% | +11.66% | 9.49B | |
| Weighted average by Cap. | -0.58% | -0.47% | -15.29% | -8.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.35B 188M 162M 152M 138M 255M 16.15B 288M 1.78B 693M 7.39B 704M 689M 27.01B | 1.49B 208M 180M 169M 153M 282M 17.89B 319M 1.97B 767M 8.19B 780M 763M 29.92B |
| Net income | 602M 83.87M 72.56M 68.08M 61.7M 114M 7.22B 129M 796M 310M 3.31B 315M 308M 12.08B | 734M 102M 88.4M 82.95M 75.17M 139M 8.8B 157M 970M 377M 4.03B 384M 375M 14.71B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,241
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-13 | 21.14 ¥ | -2.40% | 7,064,881 |
| 25-06-12 | 21.66 ¥ | +1.59% | 3,654,242 |
| 25-06-11 | 21.32 ¥ | -0.33% | 2,492,243 |
| 25-06-10 | 21.39 ¥ | -1.11% | 3,566,437 |
| 25-06-09 | 21.63 ¥ | +2.51% | 4,496,026 |
End-of-day quote Shanghai S.E., June 12, 2025
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.14CNY
Average target price
28.00CNY
Spread / Average Target
+32.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 688276 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition